Joe Schofield

Joe Schofield is a Researcher at the Population and Behavioural Science Division within the School of Medicine at the University of St Andrews. He holds a PhD and is actively engaged in addiction medicine research, focusing on substance use disorders, telemedicine applications, and the cardiovascular impacts of chronic opioid exposure. His work contributes to the United Nations Sustainable Development Goals (SDGs), particularly in health and well-being.

His research interests span:

• Substance Use Epidemiology: Investigating opioid and benzodiazepine-related harms, mortality risks, and co-prescription patterns.
• Telemedicine & Treatment Innovation: Exploring digital health solutions for opioid use disorder globally.
• Harm Reduction: Developing community-based interventions, including overdose prevention and co-production models in treatment services.
• Complex Systems Analysis: Using network analytics and participatory mapping to study drug-related deaths in Scotland.

Schofield's recent publications (2023–2025) emphasize systematic reviews, cohort studies, and scoping reviews. Key trends include telemedicine-enabled treatment frameworks, benzodiazepine-opioid interactions, and community pharmacy-led harm reduction strategies. His research employs mixed-methods approaches, with a strong focus on real-world applicability and policy impact.

He is an active contributor to academic conferences, having chaired and presented at the 2024 International Society for Addiction Medicine World Congress. No awards, grants, or supervised students are detailed in the available data.